News

CERC will be present at PCR London Valves 2025, from 16 to 18 November in London. As a specialized cardiovascular CRO, CERC partners with leading innovators to transform ideas into successful clinical outcomes, from concept to completion, worldwide. Our team will be on site to share CERC’s expertise...

Major milestone in interventional cardiology! At TCT2025, Prof. Christian Spaulding presented the 12-month results of the landmark SELUTION DeNovo trial. The study demonstrated that a treatment strategy using SELUTION SLR™ Drug-Eluting Balloon with provisional stenting when needed, was non-inferior...

CERC is proud to share that the ABILITY DIABETES GLOBAL Trial has been accepted for publication in The Lancet. Conducted under the leadership of Dr. Roxana Mehran, this study reflects a successful collaboration between Mount Sinai and CERC as CRO.

CERC (Cardiovascular European Research Center) was proud to take part in AICT AsiaPCR 2025 in Singapore this weekend. The congress opened with an impressive live educational case on left main PCI, featuring several members of the CERC Asia (Cardiovascular European Research Center Asia) Board...

During this EuroPCR week, the CERC team was proud to see numerous clinical studies featured in key sessions across the EuroPCR 2025 programme.

On March 17th, 2025, the second meeting of the LAARC initiative took place. Led by CERC within the framework of the Academic Research Consortium, this initiative aims to standardize definitions and clinical trial endpoints used in studies evaluating stroke prevention through left atrial appendage...

As 2025 begins, CERC (Cardiovascular European Research Center) is pleased to announce the launch of a strategic collaboration with the EUROPA GROUP, a key player in the field of international medical education and congress organization.